| Serial Number | 97920385 |
| Word Mark | A |
| Filing Date | Thursday, May 4, 2023 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, October 22, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 27, 2024 |
| Description of Mark | The mark consists of a circle with an "A" inside, with the horizontal line of the "A" having been replaced by a dot. |
| Goods and Services | Pharmaceutical preparations, namely, drug delivery agents in the nature of lipid nanoparticle carriers that facilitate delivery of pharmaceutical preparations and nucleic acid therapeutics as pharmaceutical preparations; pharmaceutical preparations comprised of nucleic acids, namely, messenger RNA and lipid nanoparticles for treating cancer, genetic disorders, infectious diseases, cardiovascular diseases, liver diseases, autoimmune disorders, neurological disorders, metabolic disorders; pharmaceutical preparations, namely, vaccines for human use for treating cancer, infectious diseases, cardiovascular diseases, liver diseases, autoimmune disorders, neurological disorders, metabolic disorders, genetic disorders, allergy; pharmaceutical preparations for gene silencing, for gene editing, for antibody therapeutics, for protein replacement therapeutics, and for nucleic acid therapeutics, for treating cancer, genetic disorders, infectious diseases, cardiovascular diseases, liver diseases, autoimmune disorders, neurological disorders, metabolic disorders |
| Pseudo Mark | ACUITAS |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Lipids used in the manufacture of cosmetics, beverages, food products and food supplements, lipid nanoparticles used in the manufacture of cosmetics, beverages, food products, and food supplements, lipid formulations used in the manufacture of cosmetics, beverages, food products, and food supplements; nucleic acids, namely, messenger RNA, for scientific purposes, research laboratory use |
| Goods and Services | Regulatory compliance consultancy services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid nanoparticles, nucleic acid, namely, messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology |
| Goods and Services | Research, development, and evaluation services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, namely, messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology; synthetic chemistry services, namely, design, synthesis, analysis, evaluation, and biophysical characterization of lipids, lipid formulations, and lipid nanoparticles; preclinical study services, namely, conducting scientific feasibility studies, namely, pharmacodynamic and pharmacokinetic studies, scientific feasibility studies as to the human safety and tolerability studies regarding clinical pathology and histopathology, immune response characterization studies, and bioanalytical services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, namely, messenger RNA, drug delivery agents, and nucleic acid therapeutics; scientific clinical research services, in the fields of chemical molecular analysis, pharmaceutical product optimization, and conducting clinical trial services for others in the field of pharmaceuticals; research and development of new formulation products for others, namely, vaccines and nucleic acid therapeutics; research and development for others in the fields of new pharmaceuticals, medical therapies, vaccines, gene therapies, drug delivery agents, and nucleic acid therapeutics for others; project management services for scientific research and development programs in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, namely, messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology; consultancy services in the fields of scientific research and development of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, namely, messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 2, 2023 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 2, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 2, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, October 18, 2013 |
| First Use In Commerce Date | Friday, October 18, 2013 |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 2, 2023 |
| Primary Code | 045 |
| First Use Anywhere Date | Friday, October 18, 2013 |
| First Use In Commerce Date | Friday, October 18, 2013 |
| Party Name | Acuitas Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Vancouver, B.C. V6T1Z3 CA |
| Party Name | Acuitas Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Vancouver, B.C. V6T1W5 CA |
| Event Date | Event Description |
| Monday, May 8, 2023 | NEW APPLICATION ENTERED |
| Friday, June 2, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, January 26, 2024 | ASSIGNED TO EXAMINER |
| Friday, January 26, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, January 26, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, January 26, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, April 16, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, April 16, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, April 16, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, June 3, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Sunday, May 12, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Sunday, May 12, 2024 | FINAL REFUSAL WRITTEN |
| Sunday, May 12, 2024 | FINAL REFUSAL E-MAILED |
| Thursday, July 18, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, July 18, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, July 18, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, July 18, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, July 18, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, August 7, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 27, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 27, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Friday, October 18, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, October 18, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, October 18, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, October 22, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |